how to get insurance to pay for tirzepatide New Pricing, Access Available Through Self-Pay Options Tirzepatide & Zepbound® Weight Loss

The tirzepatide doses of 10 and/or 15 mg demonstrated superiority compared to placebo for the coprimary endpoints percentage body weight reductions from baseline at week 72 and the proportion of patients achieving 5% body weight reduction at week 72

NCD Risk Factor Collaboration (NCD-RisC)

Patients often report experiencing nausea, vomiting, and gastrointestinal issues such as diarrhea or constipation when taking Zepbound

Understanding your dose options ensures you balance achieving weight goals with personal comfort and safety

Patients should be counseled that scale weight may not accurately reflect body composition changes

N Engl J Med 387(3):205216 [DOI] [PubMed] [Google Scholar] Jensen TL et al (2024) The body weight reducing effects of Tirzepatide in people with and without type 2 diabetes: a review on efficacy and adverse effects